Catechol-induced covalent modifications modulate the aggregation tendency of α-synuclein: An in-solution and

Ilenia Inciardi1, Elena Rizzotto1, Francesco Gregoris2

  • 1Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

PubMed
Summary

3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylethanol (DOPET) inhibit alpha-Synuclein aggregation, a key factor in Parkinson's disease (PD). These compounds disrupt fibril formation by forming off-pathway oligomers and inducing covalent modifications.